Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The company's first two testing locations for the general public, in Georgia and Rhode Island, will be able to deliver results in a matter of minutes.

CVS Health to Open Rapid Drive-Through COVID-19 Testing Sites

CVS Health Corp , called on by the Trump administration last month to help test Americans for infections from the new coronavirus, said it was launching two offsite testing locations with Abbott Laboratories'  faster diagnostic kit and would be able to handle 1,000 tests per day.

CVS ramps up drive-through coronavirus testing sites with faster kits

CVS Health said it hopes to perform up to 1,000 tests per day.

CVS launches drive-thru rapid testing in Rhode Island and Georgia

CVS Health is opening testing for the Coronavirus strain COVID-19 in parking lots in two more states using Abbott Laboratories rapid diagnostic test.

CVS Expands Coronavirus Parking Lot Testing To Three States

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Here are a few safe stocks to get you through today's tumultuous market.

3 Top Stocks to Buy With Dividends Yielding More Than 3%

Rite Aid

Walgreens

All three retail pharmacy giants take a step back after Walgreens withdraws its full-year outlook.

Why Walgreens Boots Alliance, CVS Health, and Rite Aid Are Falling Today

Based on historical performance, Walgreens Boots Alliance (NASDAQ: WBA) appears to be an attractive bet compared to CVS Health (NYSE: CVS) in the current crisis.

Buy Walgreens Over CVS?

Amazon

Domino's Pizza

GrubHub

Kroger

Target

Uber

Ulta Beauty

Walmart

Amid COVID-19, the importance of the delivery industry is undisputed. Our hosts take a closer look.

How the Delivery Industry Is Handling the Crisis

In the latest trading session, CVS Health (CVS) closed at $59.38, marking a -0.5% move from the previous day.

CVS Health (CVS) Stock Moves -0.5%: What You Should Know

CVS Health was already moving toward managed care before the coronavirus, making CVS stock a long-term winner here. 
The post CVS Stock Is a Winner Beyond the Pandemic appeared first on InvestorPlace.

CVS Stock Is a Winner Beyond the Pandemic

AbbVie

Advanced Micro Devices

Now's the time to add these companies to your portfolio.

4 Stocks You'll Be Glad You Bought at These Prices

Colgate-Palmolive

Should You Buy These 3 Stocks at Their 52-Week-Lows?

Papa John's

YUM! Brands

Dillard's

Many food stores and pharmacies are hiring to meet the demand of the coronavirus emergency. I list some of the openings and also review chain store closings.

Grocery Stores, Pharmacies Are Hiring To Meet Demand In The Coronavirus Emergency While Other Stores Are Closed, Except Dillard’s

UnitedHealth Group

U.S. insurers will have to pay tens (or hundreds) of billions of dollars to cover the treatment of COVID-19 patients, and we should expect them to pass those costs along.

Health Insurance Premiums Could Rise by Over 40% Due to Coronavirus, Study Warns

U.S. drugstore operator CVS Health Corp  said on Thursday its medical membership and payment collection have been hit due to the coronavirus pandemic, although it cannot reasonably estimate the impact on its businesses, cash flows or operating results.

CVS says membership, payment collection hit by coronavirus

The company had already waived co-pays for SARS-CoV-2 tests and for telemedicine services.

CVS Health's Aetna Insurance Waives Cost-Sharing and Co-Pays for COVID-19 Treatments

Anthem

Teladoc

Telehealth stocks are just beginning to push higher, as the coronavirus from China spreads and hospitals become overwhelmed with case loads.
The post 3 of the Top Telehealth Stocks to Own on Coronavirus Concerns appeared first on InvestorPlace.

3 of the Top Telehealth Stocks to Own on Coronavirus Concerns

CVS Health said it will waive co-payments and related out-of-pocket cost-sharing of commercially insured Aetna members’ “inpatient admissions related to” the Coronavirus strain COVID-19.

CVS To Waive Co-Pays For Aetna Member Coronavirus Hospitalizations

General Electric

COVID-19 is taking an enormous toll on economic and health infrastructure, thereby resulting in massive layoffs. However, there are certain companies that are challenging this downtrend.

4 Stocks Bucking the Layoff Trend Amid Coronavirus Scare

Alexion Pharma

Bristol-Myers

Jazz Pharmaceuticals

Teva Pharmaceutical

The coronavirus crash has pushed forward price-to-earnings ratios for these healthcare companies down to between 3 and 7.

5 Healthcare Stocks That Haven't Been This Cheap in at Least 10 Years

The lack of personal protective equipment has also limited the number of coronavirus tests that CVS sites are able to do.

CVS CEO Larry Merlo: Lack of protective gear for workers has slowed rollout of drive-thru testing

Companies are hiring from a growing pool of people who have lost jobs or been furloughed as the spread of the coronavirus halts travel and shuts down restaurants and hotels.

As Walmart, CVS and Domino's race to keep up with demand, they have new challenge: Hiring during a pandemic

Dollar General

Several retail stores, including supermarkets, grocery chains, medical and pharmacy stores, take-away restaurants and e-commerce companies are hiring people.

6 Stocks in Focus on Hiring Spree Despite Market Turmoil

PepsiCo

Coronavirus has drastically shifted the world's buying habits, and businesses are rapidly adjusting to the new pandemic reality.

These companies are hiring thousands during the coronavirus pandemic

The coronavirus pandemic will require the pharmacy operator to staff up.

News for CVS Health Stock (CVS)